MARKET PULSE-Revance, Arotech, Medidata, Lexmark, MGIC, GW Pharma

Tue Apr 22, 2014 10:37am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For more market insights, including options activity, click on ; for the Day Ahead newsletter; for the Morning News Call newsletter,

April 22 (Reuters) - U.S. stocks rose on Tuesday, with both the S&P 500 and Nasdaq on track for a sixth straight day of gains as a number of bellwether companies reported strong results. The Dow Jones industrial average was up 0.41 percent at 16,517.39, the S&P 500 was up 0.42 percent at 1,879.84 and the Nasdaq Composite was up 0.79 percent at 4,154.088.

** REVANCE THERAPEUTICS INC, $33.55, +17.23 pct

The company said on Monday an experimental long-lasting form of botulinum toxin - the same compound used in Allergan Inc's Botox - met the main goal of reducing wrinkles in patients in an early stage trial.

Cowen & Co analysts estimated the product could eventually generate $1 billion in sales.

** ALLERGAN INC, $164.94, +16.15 pct

** VALEANT PHARMA, $132.59, +5.22 pct   Continued...